Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa | Zendy

Sandra Mikhail | Zendy; Nivedita B. Singh | Zendy; Razieh Kebriaei | Zendy; Seth Rice | Zendy; Kyle Stamper | Zendy; Mariana Castanheira | Zendy; Michael J. Rybak | Zendy

Open Access

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

Author(s) -

Sandra Mikhail,

Nivedita B. Singh,

Razieh Kebriaei,

Seth Rice,

Kyle Stamper,

Mariana Castanheira,

Michael J. Rybak

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00779-19

Subject(s) - fosfomycin , aztreonam , colistin , klebsiella pneumoniae , amikacin , microbiology and biotechnology , meropenem , ceftazidime/avibactam , ceftazidime , pseudomonas aeruginosa , antibiotics , medicine , biology , imipenem , antibiotic resistance , bacteria , escherichia coli , biochemistry , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research